news 
Title: IXI raises $36.5M from Amazon and more to bring the concept of autofocus to prescription glasses
IXI, a Finnish company, has secured $36.5 million in funding from investors including Amazon’s Alexa Fund to revolutionize the way we correct our vision. The startup is working on developing autofocus technology for prescription glasses, which could change the game for people with vision impairments.
IXI’s innovative approach involves using eye-tracking and algorithmic adjustments to liquid crystal lenses, allowing for real-time vision correction. This technology has already been proven in lab settings, and the company is now looking to bring it to market.
The funding will be used to further develop the product and prepare it for regulatory approvals. IXI declined to provide a timeline for when we can expect to see this innovative technology on store shelves.
IXI’s pedigree and track record of execution are significant reasons why investors are so enthusiastic about this project. The company’s founders have extensive experience in hardware development, particularly in advanced optics and eye-tracking technologies.
The investment from Amazon’s Alexa Fund is noteworthy, as it demonstrates the company’s growing interest in the eyewear space. This follows recent news that Amazon is working on special glasses for delivery drivers to help them more quickly deliver packages.
IXI’s technology has the potential to not only improve human eyesight but also create new opportunities for Amazon in the realm of mixed-reality eyewear and pharmacy services.
Source: https://techcrunch.com/2025/04/28/ixi-raises-36-5m-from-amazon-and-more-to-bring-the-concept-of-autofocus-to-prescription-glasses/
